x
Filter:
Filters applied
- Congenital: Fontan
- Research ArticleRemove Research Article filter
- single ventricleRemove single ventricle filter
Publication Date
Please choose a date range between 2018 and 2021.
Author
- Fogel, Mark A3
- Trusty, Phillip M2
- Wei, Zhenglun2
- Yoganathan, Ajit P2
- Attard, Chantal1
- Biko, David M1
- Briody, Julie1
- Cordina, Rachael1
- D'Udekem, Yves1
- Figliola, Richard1
- Giridharan, Guruprasad A1
- Goldberg, David J1
- Harris, Matthew A1
- Hassan, Ebrahim Bani1
- Ignjatovic, Vera1
- Jonas, Travis1
- Kanter, Kirk R1
- Mackay, Mark T1
- Marsden, Alison1
- Monagle, Paul T1
- Neary, Michael1
- Ozcelik, Nazire1
- Partington, Sara L1
- Rice, Kathryn1
- Rodefeld, Mark D1
Congenital: Fontan
5 Results
- Congenital: Fontan
Imposition of Fontan physiology: Effects on strain and global measures of ventricular function
The Journal of Thoracic and Cardiovascular SurgeryVol. 162Issue 6p1813–1822.e3Published online: February 16, 2021- Kazuhiro Shiraga
- Nazire Ozcelik
- Matthew A. Harris
- Kevin K. Whitehead
- David M. Biko
- Sara L. Partington
- and others
Cited in Scopus: 5We sought to evaluate contractile function in single-ventricle patients before and after imposition of Fontan physiology. - Congenital: Fontan
Long-term outcomes of warfarin versus aspirin after Fontan surgery
The Journal of Thoracic and Cardiovascular SurgeryVol. 162Issue 4p1218–1228.e3Published online: January 4, 2021- Chantal Attard
- Paul T. Monagle
- Yves d'Udekem
- Mark T. Mackay
- Julie Briody
- Rachael Cordina
- and others
Cited in Scopus: 11Because of the nature of the Fontan physiology, patients are at an increased risk of thromboembolic complications. As such, warfarin or aspirin is generally prescribed lifelong for thromboprophylaxis. This study aimed to compare long-term rates of cerebrovascular injury, thrombosis, bleeding, bone mineral density, and quality of life in people living with Fontan circulation receiving warfarin compared with aspirin. - Congenital: FontanOpen Archive
Cavopulmonary assist: Long-term reversal of the Fontan paradox
The Journal of Thoracic and Cardiovascular SurgeryVol. 158Issue 6p1627–1636Published online: August 28, 2019- Mark D. Rodefeld
- Alison Marsden
- Richard Figliola
- Travis Jonas
- Michael Neary
- Guruprasad A. Giridharan
Cited in Scopus: 29Fontan circulatory inefficiency can be addressed by replacing the missing subpulmonary power source to reverse the Fontan paradox. An implantable cavopulmonary assist device is described that will simultaneously reduce systemic venous pressure and increase pulmonary arterial pressure, improving preload and cardiac output, in a univentricular Fontan circulation on a long-term basis. - Congenital: FontanOpen Archive
Y-graft modification to the Fontan procedure: Increasingly balanced flow over time
The Journal of Thoracic and Cardiovascular SurgeryVol. 159Issue 2p652–661Published online: July 10, 2019- Phillip M. Trusty
- Zhenglun Wei
- Megan Sales
- Kirk R. Kanter
- Mark A. Fogel
- Ajit P. Yoganathan
- and others
Cited in Scopus: 14The use of Y-grafts for Fontan completion is hypothesized to offer more balanced hepatic flow distribution (HFD) and decreased energy losses. The purpose of this study was to evaluate the hemodynamic performance of Y-grafts over time using serial cardiac magnetic resonance data and to compare their performance with extracardiac Fontan connections. - Congenital: FontanOpen Archive
Impact of hemodynamics and fluid energetics on liver fibrosis after Fontan operation
The Journal of Thoracic and Cardiovascular SurgeryVol. 156Issue 1p267–275Published online: March 7, 2018- Phillip M. Trusty
- Zhenglun Wei
- Jack Rychik
- Pierre A. Russo
- Lea F. Surrey
- David J. Goldberg
- and others
Cited in Scopus: 34The staged Fontan procedure has shown promising short-term outcomes in patients with single ventricles. However, Fontan-associated liver disease is a marked problem as patients age. The purpose of this study is to investigate the relationship between hemodynamics and liver fibrosis in patients undergoing the Fontan.